Oral Argument before the Commission in the Matter of Impax LaboratoriesPrimary tabs

FTC Headquarters, Room 532, Washington, DC

Event Description

Oral Argument Open to the Public and Executive Session Closed to the Public: Oral argument before the Commission In the Matter of Impax Laboratories, Inc., Docket No. 9373, at 600 Pennsylvania Avenue, N.W., Room 532, Washington, D.C. 20580. Immediately following oral argument, the Commission will meet in an executive session closed to the public.  The vote to close the meeting for the executive session was 4-0 with Commissioner Ohlhausen not participating. Expected to attend the closed meeting are the Commissioners themselves, advisors to the Commissioners, and such other Commission staff as may be appropriate.

In accordance with the provisions of the Government in the Sunshine Act, notice is given that the Federal Trade Commission has determined and the General Counsel has certified that the executive session will be closed to the public pursuant to 5 U.S.C. Sections 552b(c)(10) and 552b(d)(4) and that the public interest does not require the executive session to be open to the public.  Contact: Donald S. Clark, Secretary, (202) 326-2514.

Event Details